伊萨图西马布治疗复发性和/或耐火性AL Amyloidosis:前性第二阶段试验 (SWOG S1702) 的结果
Terri L Parker1, Adam Rosenthal2, Vaishali Sanchorawala3
1Department of Medical Oncology and Hematology, Yale University School of Medicine, New Haven, CT.
Blood
|September 9, 2025
概括
一种CD38抗体的伊萨图西马布在复发轻链粉样性粉症的患者中显示出显著的血液和器官反应. 这种治疗表明了有利的安全性,为这种罕见疾病提供了新的选择.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 轻链 (AL) 氨基粉症是一种罕见的血细胞疾病.
- 反CD38单克隆抗体在治疗血细胞疾病方面表现有前途.
- 伊萨图キシ马布向CD38,这是血细胞高度表达的蛋白质.
研究的目的:
- 为了评估伊萨图キシ马布单一治疗的疗效和安全性.
- 评估复发AL粉样性病患者的血液和器官反应.
- 为了确定与伊萨图キシ马布治疗相关的整体反应率和不良事件.
主要方法:
- 一个多中心,合作性小组第二阶段试验.
- 登记了43名患有复发AL氨基粉症的患者.
- 伊萨图西马布在第一个周期内每周静脉注射20mg/kg,然后每隔一周进行24个周期.
主要成果:
- 观察到77.1%的整体血液学反应率.
- 57%的患者实现了非常好的部分反应 (VGPR) 或更好.
- 器官反应:50%的反应和57%的心脏反应.
- 最常见的3级以上的不良事件:淋巴缺血 (8.5%) 和感染 (6%).
结论:
- 伊萨图克西马布单一治疗在先前治疗AL氨基粉症的患者中显示出显著的疗效.
- 这种治疗与良好的安全性相关.
- 伊萨图西马布代表了复发AL粉样性粉症的潜在新疗法选择.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
495
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
495
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
506
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
506
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K


